BiotechTube
iSono Health

iSono Health

San Francisco, United States· Est.
isonohealth.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $22M

Overview

iSono Health is pioneering accessible breast cancer screening and monitoring with its FDA-cleared ATUSA system, an automated, portable 3D ultrasound scanner. The technology captures a whole breast volume in two minutes without requiring a trained sonographer, targeting integration into physician offices and women's health clinics. Its value proposition centers on standardization, speed, and the potential for AI-enhanced longitudinal tracking, particularly for high-risk patients. The company is pre-revenue, focusing on commercial deployment and development of its AI-driven software features.

OncologyWomen's Health

Technology Platform

ATUSA: An integrated hardware and software platform featuring a wearable accessory and automated 3D ultrasound scanner for hands-free, whole-breast volume capture. The system is designed for operator-agnostic use at point-of-care and is architected to integrate AI-driven analysis and cloud-based longitudinal monitoring.

Funding History

2
Total raised:$22M
Series A$15M
Seed$7M

Opportunities

The large population of women with dense breast tissue, for whom mammography is less effective, represents a major addressable market for adjunctive screening.
The system's portability and ease of use also create an opportunity to expand breast imaging access into underserved areas and primary care settings, enabling new models for longitudinal monitoring of high-risk patients.

Risk Factors

Key risks include uncertain insurance reimbursement, which is critical for adoption, and the challenge of competing against established ultrasound manufacturers with vast sales networks.
The company also faces technology risk in successfully developing and gaining regulatory clearance for its promised AI features.

Competitive Landscape

iSono Health competes with traditional ultrasound systems from giants like GE HealthCare, Siemens Healthineers, and Philips, which require trained operators. It also faces competition from other breast imaging modalities like contrast-enhanced mammography and abbreviated MRI. Its primary differentiation is the combination of full automation, 3D whole-breast capture, portability, and a built-in path for AI integration.

More companies in Diagnostics & Precision Medicine →More companies in United States →